PALADIN LABS INC has a total of 42 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and South Africa. Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are NATURE TECHNOLOGY INC, VIRACTA THERAPEUTICS INC and CISTRON BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | South Africa | 4 | |
#4 | Canada | 2 | |
#5 | Mexico | 2 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Medical technology | |
#5 | Chemical engineering | |
#6 | Machines | |
#7 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Macromolecular compounds compositions | |
#6 | Compounding ingredients | |
#7 | Medical purpose containers | |
#8 | Mixing | |
#9 | Compounding processes | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Smith Damon | 25 |
#2 | Sant Vinayak | 20 |
#3 | Rahmouni Miloud | 18 |
#4 | Gervais Sonia | 17 |
#5 | Bichara Ali | 16 |
#6 | El-Jammal Ali | 14 |
#7 | Ndong Jean-Michel | 14 |
#8 | Duffayet Frederic | 13 |
#9 | Rustom Shams | 13 |
#10 | Boursiquot Bobby-Ernst | 8 |
Publication | Filing date | Title |
---|---|---|
CA2690824A1 | Methadone formulation | |
EP2379111A1 | Narcotic drug formulations with decreased abuse potential | |
EP2331629A1 | Starch-based microparticles for the release of agents disposed therein | |
CA2704262A1 | Ingestible film composition | |
US2005013828A1 | Chimeric antigens for eliciting an immune response | |
US2005031628A1 | Chimeric antigens for breaking host tolerance to foreign antigens | |
US8029803B2 | Chimeric antigens for eliciting an immune response |